European Pharmaceutical Review

JANUARY 25, 2024

According to Eurostat, only 57 percent of people in the 55-74 age group use the internet regularly, and only 54 percent of Europeans possess basic digital skills The Pharmaceutical Group of the European Union (PGEU) presents a compelling argument against the proposed POD policy. Article 63 EMA (29 January 2020).

Packaging 98

Packaging Documentation Communication Pharmaceutical Companies 98

pharmaphorum

DECEMBER 28, 2022

In 2018, over 60% of all new molecular entities came from smaller biopharma firms, compared with just over 30% in 2009. So, how do smaller pharmaceutical companies at the cutting edge get ready for their acquisition milestone, so they maximise their value and attractiveness?

Pharmaceutical Manufacturing 119

Pharmaceutical Manufacturing Documentation Pharmaceutical Companies Pharmaceutical Companies 119

European Pharmaceutical Review

AUGUST 24, 2023

This heightened focus from regulators is shifting the type of deals pharmaceutical companies are willing to execute, Baral noted. These mega deals created behemoth companies that needed to spread capital too thin and included redundancies due to unrealised synergies.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 98

PharmaState Academy

DECEMBER 18, 2024

Name Email Phone Number Company Department Designation 1 / 20 How can scientific communication contribute to better collaboration between pharmaceutical companies and research institutions? a) 2009 b) 2010 c) 2012 d) 2014 13 / 20 What is the primary goal of scientific communication in pharma marketing?

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies 52

Eye on FDA

JANUARY 9, 2022

As noted in the past, there are two primary means for understanding the agency’s latest thinking with respect to promotional communications from pharmaceutical companies – the content and pattern of enforcement and the issuance of guidance documents to shed light on the parameters that exist. in November 2009.

Communication 64

Communication Documentation Labelling Pharmaceutical Companies 64

Pharma Marketing Network

MARCH 25, 2023

Pharmaceutical advertising is a crucial aspect of promoting and marketing drugs to the public. With the increase in competition, it has become essential for pharmaceutical companies to find the most effective methods of advertisement to reach their target audience. ” Pharmacy and Therapeutics, 2009.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Express Pharma

SEPTEMBER 6, 2023

What’s more, with many key biologics scheduled to lose patent protection in this decade, Indian pharmaceutical companies ought to seize this opportunity and leverage innovative technologies to introduce quality and way more affordable biosimilars in the domestic as well as global markets.

Insurance Coverage and Processing 59

Insurance Coverage and Processing Biosimilars Generic Medicine Drug Pricing 59

Syner-G

AUGUST 9, 2022

IMPACT (now part of Syner-G BioPharma Group) has been providing Regulatory Affairs support to a mid-size pharmaceutical company since 2009. Even though this company has a Regulatory Affairs Department, their rapid growth over the years has made “in-sourcing” of help a necessity.

Labelling 40

Labelling Pharmaceutical Companies Pharmaceutical Companies 40

Syner-G

AUGUST 21, 2022

In 2009, IMPACT (now part of Syner-G BioPharma Group) was contracted by a mid-size global pharmaceutical company to prepare 2 Phase 3 clinical study reports (CSRs) for a biologic agent for the treatment of Crohn’s disease. Download a PDF of this case study. Establishment of a Long-Term Medical Writing Partnership.

Documentation 40

Documentation Pharmaceutical Companies Pharmaceutical Companies 40

Eye on FDA

JULY 7, 2020

For some years CDER published its Guidance Agenda to include a guidance on the use of links to third party websites by pharmaceutical companies. OPDP has indicated in the past that the use of sponsored links without risk information is a no-no. This item disappeared from the agenda, however, and no draft guidance was issued.

Communication 52

Communication Documentation Labelling Pharmaceutical Companies 52

Pharmaceutical Technology

OCTOBER 5, 2008

“The business integration from 2005 to 2007 of the two separate companies to form the joint Daiichi Sankyo created one of Japan’s biggest pharmaceutical companies.” ” “The use of generic drugs is low in Japan, but health costs are increasing and the government has to do something to reduce costs.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Labelling Diabetes 40

Pharmaceutical Technology

MAY 11, 2008

Pharmaceutical companies, regulatory agencies and governments are becoming increasingly concerned about fraud and counterfeiting throughout the pharmaceutical supply chain, especially with the cost of drugs going up.

Packaging 40

Packaging Labelling Pharmaceutical Companies Pharmaceutical Companies 40

pharmaphorum

JULY 14, 2021

He was referring to his business’ share of misconduct related fines that, between 2009 and 2017, topped $342 billion across the US and Europe. It’s killing us.” As the sector looks to maintain its momentum, it must be wary that positive messaging and increased scrutiny does not end up as a recipe for a hard fall.

Communication 105

Communication Pharmaceutical Companies Pharmaceutical Companies Vaccines 105

pharmaphorum

MARCH 30, 2021

Camilla has a well-recognised track record working with various multinational companies, including AstraZeneca, Novartis and Allergan. About the author.

Hospitals 111

Hospitals Communication Drug Development Pharmaceutical Companies 111

PharmaShots

FEBRUARY 21, 2023

The company expects to commence P-I clinical trials on metastatic and pediatric primary bone cancer patients. Other radiotherapies under the company's pipeline include Humalutin and Alpha37. The company is evaluating Iomab-B in a P-III clinical trial (SIERRA) in patients with relapsed or refractory acute myeloid leukemia (AML).

Dosage 56

Dosage Labelling Immunity Immunization 56

Pharma Marketing Network

JUNE 11, 2020

So, this was back in 2009, and I hosted a Halloween party at my house, and I decided to dress up as Hunter S. You know, in November 2009, the FDA held a public hearing about the promotion of Food and Drug Administrative Related Regulated Medical Products, using the internet and social media tools. So, I didn’t look so bad.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies Diabetes 52

Pharmaceutical Technology

FEBRUARY 1, 2023

RSV researchers at major pharmaceutical companies are currently working to develop new RSV drugs to beat future waves of RSV infection and gain the first RSV vaccine FDA approval. Pharmaceutical companies are pushing to develop drugs and vaccines for RSV with these populations in mind.

Vaccines 64

Vaccines Drug Development Pharmaceutical Companies Pharmaceutical Companies 64

PharmaShots

MARCH 29, 2023

Shots: Drug patent expiry is when a patent granted to a pharmaceutical company for a particular drug expires, allowing other companies to produce and sell generic versions Like every other utility patent, pharmaceuticals also get market exclusivity of 20 years. No generic version of Entresto has been approved in the US.

Biosimilars 49

Biosimilars Diabetes Chemotherapy Immunity 49

pharmaphorum

SEPTEMBER 18, 2020

But although it was dubbed a “dangerous game”, some companies came out on top… On 6th April 1999, two companies with similar science-based cultures and a shared vision of the pharmaceutical industry came together to form what’s now considered as one of the top ten pharma companies in the world: AstraZeneca.

Vaccines 116

Vaccines Pharmaceutical Companies Pharmaceutical Companies Drug Development 116

Pharmaceutical Technology

MARCH 22, 2023

Large-molecule drugs such as biologics are particularly sensitive to foreign contamination and E&L interaction, making these issues key concerns for pharmaceutical companies. In addition, packaging components are not entirely manufactured in a clean room environment, making them a potential source of exogenous contamination.

Packaging 52

Packaging Compounding Pharmaceutical Companies Pharmaceutical Companies 52

Express Pharma

APRIL 16, 2024

Indian pharmaceutical companies play a crucial role in fulfilling global demand for critical vaccines, including those endorsed by the World Health Organization (WHO) for diseases (like Tetanus, Pertussis, Diphtheria, and Bacillus Calmette-Guerin), highlighting India’s indispensable contribution to global immunization efforts.

Vaccines 105

Vaccines Generic Medicine Pharmaceutical Companies Pharmaceutical Companies 105

PharmaShots

JUNE 7, 2023

To further expedite the introduction of the biosimilar globally, EirGenix has been in talks with global pharmaceutical companies about licensing the marketing rights to EG1206A 5. The P-III trial of EG1206A is expected to be initiated shortly, estimated that the evaluation of the primary EPs will be completed within 2yrs.

Biosimilars 40

Biosimilars Packaging Diabetes Pharmaceutical Companies 40

PharmaShots

APRIL 13, 2023

model is a holistic approach to incorporate the same strategy to life science and pharmaceutical companies. A globally fast-growing, and largest pharmaceutical company in the world was created through a merger between Pfizer and Pharmacia. Model: Inspired by the industry 4.0 model, the pharma 4.0

Biosimilars 40

Biosimilars Vaccines Pharmaceutical Companies Pharmaceutical Companies 40

Express Pharma

MAY 10, 2024

Indian pharmaceutical companies play a crucial role in fulfilling global demand for critical vaccines, including those endorsed by the World Health Organization (WHO) for diseases (like Tetanus, Pertussis, Diphtheria, and Bacillus Calmette-Guerin), highlighting India’s indispensable contribution to global immunisation efforts.

Vaccines 105

Vaccines Generic Medicine Pharmaceutical Companies Pharmaceutical Companies 105

PharmaShots

FEBRUARY 20, 2023

After the outbreak of any epidemic or pandemic, all the responsibilities come on the shoulders of pharmaceutical companies. With unprecedented diseases lurking on the corner, pharmaceutical companies, are now obligated to widen their conventional horizons and look for substitute practices in their drug development strategies.

Vaccines 40

Vaccines Pharmaceutical Companies Pharmaceutical Companies Drug Development 40

pharmaphorum

DECEMBER 2, 2020

Like most pharma companies of its size, Pfizer has faced its fair share of controversy as one of the most well-known drugmakers in the world. Since the turn of the millennium, Pfizer has embarked on a series of mega-mergers, gobbling up Warner-Lambert in 2000, Pharmacia and Upjohn in 2002, Wyeth in 2009, and Medivation in 2016.

Compounding 128

Compounding Vaccines Biosimilars Diabetes 128

pharmaphorum

JANUARY 5, 2021

For pharmaceutical companies there are a number of implications. For pharmaceutical companies, this may mean a change in patient journeys to pharmacotherapy becoming longer and more complex, but also occurring in different settings. It will take a decade to fully evaluate the true impact.

Hospitals 105

Hospitals Vaccines Pharmaceutical Companies Pharmaceutical Companies 105

Pharmaceutical Technology

AUGUST 26, 2008

It was once derided as the stuff of science fiction, but in recent years, biotechnology has emerged as an important growth area in pharmaceuticals. As understanding of biological systems has forged ahead, pharmaceutical companies have made increasing use of biotechnology in discovering and manufacturing new medicines.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Vaccines Drug Development 40

pharmaphorum

FEBRUARY 16, 2021

Slaoui rose through the ranks at the big UK pharma and was appointed head of the company’s vaccines division in 2009, leaving in 2017 when Emma Walmsley took over as CEO at GSK.

Vaccines 59

Vaccines Pharmaceutical Companies Pharmaceutical Companies Drug Development 59